Dr Reddy's announces launch of Sildenafil tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

This followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, a company statement said here.

The Revatio brand had US sales of approximately $38.67 million for the most recent twelve months ending September 2012, according to IMS Health.

Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes, the release said.


  • All the debates are glossing over the key question if children are eating healthy food

    For some time now, we have been strapped in noodle debates. First Maggie noodles and now our own swadeshi noodles that Baba Ramdev is making.


Stay informed on our latest news!


Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs


Amita Sharma

Smart cities for the smart citizens

The 21st century has been spoken of as the urban ...

Zehra Naqvi

Baby and you

Every person who’s had a chance to be a parent ...

Bubbles Sabharwal

Women of the world, unite for a change

Last week I attended the Women in the World forum ...


William D. Green

Chairman & CEO, Accenture